A study investigated the effects of rosemary extract on triple-negative breast cancer cells, focusing on its impact on cell proliferation, survival, and key signaling pathways. The findings revealed that rosemary extract inhibited cell proliferation and survival by modulating the Akt and mTOR signaling pathways, suggesting its potential as a therapeutic agent against this aggressive form of breast cancer.